Sign in
SCHEDULE 13G/A

Statement of Beneficial Ownership

CRESCENT BIOPHARMA, INC. Filed Acc 0000902664-26-004580

Stakes reported in this filing

Reporting person Shares Of the class
Vestal Point Capital, LP 3,000,000 8.1%
Ryan Wilder 3,000,000 8.1%

Members of a group can each report the same shares, so these rows overlap and don't add up.

Loading xslSCHEDULE_13G_X02/primary_doc.xml…